Literature DB >> 11300293

Histopathological characterization of melorheostosis.

K Hoshi1, N Amizuka, T Kurokawa, K Nakamura, R Shiro, H Ozawa.   

Abstract

Melorheostotic bone was examined histopathologically. In the severely affected areas, an abundance of osteoid and increased angiogenesis was observed. Increased osteoid without mineralization indicated the overproduction of bone matrix. Bone resorption also appeared to increase because osteoclasts were numerous in melorheostotic bone, thus suggesting a high rate of bone turnover. In addition, transforming growth factor-beta was immunolocalized in the periosteal fibroblasts, mesenchymal cells surrounding vessels, endothelial cells, and osteoblasts, while basic fibroblast growth factor was found in endothelial cells and mast cells near vessels. These cytokines may have some association with the exuberant bone matrix production and angiogenesis in melorheostosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11300293     DOI: 10.3928/0147-7447-20010301-20

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  4 in total

1.  Melorheostosis: A Clinical, Pathologic, and Radiologic Case Series.

Authors:  Cameron N Fick; Nadja Fratzl-Zelman; Paul Roschger; Klaus Klaushofer; Smita Jha; Joan C Marini; Timothy Bhattacharyya
Journal:  Am J Surg Pathol       Date:  2019-11       Impact factor: 6.394

Review 2.  Melorheostosis: a Rare Sclerosing Bone Dysplasia.

Authors:  Anupam Kotwal; Bart L Clarke
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

3.  Somatic activating mutations in MAP2K1 cause melorheostosis.

Authors:  Heeseog Kang; Smita Jha; Zuoming Deng; Nadja Fratzl-Zelman; Wayne A Cabral; Aleksandra Ivovic; Françoise Meylan; Eric P Hanson; Eileen Lange; James Katz; Paul Roschger; Klaus Klaushofer; Edward W Cowen; Richard M Siegel; Joan C Marini; Timothy Bhattacharyya
Journal:  Nat Commun       Date:  2018-04-11       Impact factor: 14.919

4.  Bone vascularization in normal and disease conditions.

Authors:  Christian Carulli; Massimo Innocenti; Maria Luisa Brandi
Journal:  Front Endocrinol (Lausanne)       Date:  2013-08-26       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.